SCHEMBL27508573

SCHEMBL27508573

Cc1cc(I)ccc1Nc1c(F)cccc1C(=O)NO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
PTGS2 P35354 1/20 0.43
IDO1 P14902 2/20 0.42
MAP2K1 Q02750 10/20 0.41
MAP2K2 P36507 5/20 0.41
HDAC3 O15379 2/20 0.40
HDAC4 P56524 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC7 Q8WUI4 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC10 Q969S8 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
HDAC9 Q9UKV0 2/20 0.40
HDAC5 Q9UQL6 2/20 0.40
PIM1 P11309 1/20 0.40
CAMK2B Q13554 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27469368 0.89 MEN1 (0.51) MEN1KMT2ATDP1PTGS2IDO1
SCHEMBL27471400 0.88 MAP2K1 (0.53) IDO1MAP2K1MAP2K2HDAC3HDAC4
SCHEMBL6035920 0.87 MAP2K1 (0.55) MEN1KMT2ATDP1PTGS2IDO1
SCHEMBL7715687 0.86 MAP2K1 (0.56) MEN1KMT2ATDP1PTGS2IDO1
SCHEMBL27455273 0.85 MEN1 (0.49) MEN1KMT2ATDP1PTGS2IDO1
SCHEMBL5388138 0.85 MAP2K1 (0.60) MEN1KMT2ATDP1MAP2K1MAP2K2
SCHEMBL27583296 0.85 MAP2K1 (0.61) MEN1KMT2ATDP1PTGS2MAP2K1
SCHEMBL27577420 0.83 KMT2A (0.40) MEN1KMT2APTGS2MAP2K1MAP2K2
SCHEMBL5403672 0.82 MEN1 (0.66) MEN1KMT2ATDP1IDO1MAP2K1
SCHEMBL27485120 0.82 MEN1 (0.55) MEN1KMT2ATDP1MAP2K1MAP2K2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1163475-C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors ��ʲ 2004-08-25 CN claimed
CN-1383823-A Methods of treating or inhibiting neutrophil chemotaxis by administering MEK inhibitors WARNER LAMBERT CO (US) 2002-12-11 CN claimed
CN-1373660-A Method for treating chronic pain using MEK inhibitors WARNER LAMBERT CO (US) 2002-10-09 CN claimed
CN-1261877-A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors WARNER LAMBERT CO (US) 2000-08-02 CN claimed
CN-1163475-C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors ��ʲ 2004-08-25 CN disclosed
CN-1383823-A Methods of treating or inhibiting neutrophil chemotaxis by administering MEK inhibitors WARNER LAMBERT CO (US) 2002-12-11 CN disclosed
CN-1373660-A Method for treating chronic pain using MEK inhibitors WARNER LAMBERT CO (US) 2002-10-09 CN disclosed
CN-1261877-A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors WARNER LAMBERT CO (US) 2000-08-02 CN disclosed